Syllabus
BCIDP Prep Course (BCIDP)
73 lessons. Online and self-paced.
Blueprint Foundations
Introduces the BCIDP practice perspective, blueprint-linked reasoning model, and core infection science needed for pharmacist-level decision making.
- 1BCIDP Domain Map
- 2Pharmacist Scope Boundaries
- 3Case Reasoning Framework
- 4Pathogen Classes And Syndromes
- 5Virulence And Biofilm
- 6Host Response Patterns
- 7Healthcare Exposure Risks
- 8Resistance Mechanism Principles
- 9Empiric Risk Stratification
Microbiology And Diagnostics
Covers specimen quality, diagnostic methods, susceptibility interpretation, rapid testing, and clinically meaningful microbiology use for pharmacists.
- 10Specimen Quality Principles
- 11Culture And Microscopy Basics
- 12Molecular And Antigen Tests
- 13MIC And Breakpoint Concepts
- 14Phenotype And Genotype Correlation
- 15Antibiogram Interpretation
- 16Inflammatory Biomarker Use
- 17Colonization Versus Infection
- 18Contaminant Recognition Patterns
Antimicrobial Agents
Reviews major antibacterial, antiviral, antifungal, and antiparasitic drug groups with mechanism, spectrum, PK/PD, toxicity, interactions, and pharmacist-level optimization.
- 19Beta-Lactam Spectrum Patterns
- 20Gram-Positive Targeted Agents
- 21Gram-Negative Targeted Agents
- 22Novel Resistance Agents
- 23Herpesvirus And Influenza Agents
- 24Antifungal Class Comparisons
- 25Therapeutic Antifungal Monitoring
- 26Core Antiparasitic Therapies
- 27Antiretroviral Class Framework
- 28ART Interaction Management
Assessment And PKPD
Develops patient-specific assessment, dosing individualization, penetration principles, and monitoring frameworks central to BCIDP therapeutics.
- 29Clinical Severity Stratification
- 30Social And Adherence Factors
- 31Special Population Modifiers
- 32Time And Concentration Targets
- 33Renal And Hepatic Dosing
- 34Dialysis And Extracorporeal Dosing
- 35Tissue Penetration Principles
- 36Vancomycin And Aminoglycoside Monitoring
- 37Early Response Reassessment
Syndrome-Based Bacterial Therapy
Applies antimicrobial selection and optimization across core bacterial infectious syndromes commonly tested on BCIDP.
- 38Community Respiratory Infections
- 39Hospital Pneumonia Regimens
- 40Skin And Soft Tissue Therapy
- 41Endocarditis Pharmacotherapy
- 42Bone And Joint Regimens
- 43CNS Infection Selection
- 44Intra-Abdominal And Hepatic Therapy
- 45Urinary And Gynecologic Regimens
- 46Sexually Transmitted Infection Therapy
Viral Fungal And Parasitic Syndromes
Addresses HIV, opportunistic infections, invasive fungal disease, viral therapeutics, and travel-related parasitic scenarios.
- 47Initial ART Selection
- 48OI Treatment And Prophylaxis
- 49Virologic Failure Assessment
- 50Candidiasis Treatment Pathways
- 51Mold-Active Therapy Selection
- 52Cryptococcal Regimen Phases
- 53Malaria Prevention And Treatment
- 54Traveler's Diarrhea Strategies
- 55Protozoal And Helminthic Cases
Implementation And Monitoring
Covers medication administration, toxicity mitigation, de-escalation, transitions of care, and patient counseling within pharmacist practice.
- 56IV To PO Conversion
- 57Beta-Lactam Allergy Assessment
- 58Adverse Effect Prevention
- 59Clinical Response Endpoints
- 60Spectrum Narrowing Decisions
- 61Duration Optimization Principles
- 62OPAT And COPAT Planning
- 63Interprofessional Handoff Elements
- 64Patient And Caregiver Counseling
Stewardship And Professional Practice
Completes BCIDP preparation with antimicrobial stewardship operations, prevention responsibilities, literature evaluation, informatics, and quality improvement.
- 65Stewardship Standards And Strategies
- 66Metrics And Resistance Tracking
- 67Formulary And Antibiogram Decisions
- 68Immunization In ID Practice
- 69Postexposure And Chronic Prophylaxis
- 70Pharmacist Infection Prevention Role
- 71Drug Information Resources
- 72Literature Appraisal Basics
- 73Clinical Informatics And Improvement